141Curated trials
Enterprise Evidence Report · NR-REPORT-V2.0
Switzerland
Neuroscience Intelligence
Switzerland neuroscience evidence report: current clinical, research, institution and source-linked intelligence.
Evidence rank #12 of 50 · Data maturity A · Research score 41.9 · Data confidence 100.0 / 100 · Snapshot 2026-10-12 03:36 UTC.
44Recruiting trials
249Publications
135Institutions
Executive interpretation
Switzerland ranks #12 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.
Methodology status
Methodology NR-REPORT-V2.0. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.
Methodology →Leading sponsors
University Hospital, Basel, Switzerland176 recruiting
University of Zurich143 recruiting
Insel Gruppe AG, University Hospital Bern126 recruiting
University Hospital, Geneva52 recruiting
Merck Sharp & Dohme LLC51 recruiting
AbbVie51 recruiting
Hoffmann-La Roche53 recruiting
Luzerner Kantonsspital32 recruiting
Pfizer31 recruiting
Biogen21 recruiting
Disease activity
Parkinsons21trials
Stroke15trials
Alzheimers14trials
Multiple Sclerosis13trials
Epilepsy11trials
Other Neurology10trials
Adhd3trials
Neuromuscular3trials
Depression3trials
Migraine Headache3trials
Research institutions
Alliance for Health Policy and Systems ResearchOpenAlexlinked institution
Valens ClinicsOpenAlexlinked institution
Bühler (Switzerland)OpenAlexlinked institution
Università della Svizzera italianaOpenAlexlinked institution
Roche (Switzerland)OpenAlexlinked institution
European Society of Clinical Microbiology and Infectious DiseasesOpenAlexlinked institution
Laboratory of Physical ChemistryOpenAlexlinked institution
Hôpital de MorgesOpenAlexlinked institution
Global Antibiotic Research & Development PartnershipOpenAlexlinked institution
Universitätsklinik BalgristOpenAlexlinked institution
Clinical evidence trail
NCT07777419Impact of Subthalamic Nucleus Deep Brain Stimulation on COGnitive and PSYchiatric Symptoms in Parkinson's DiseaseRECRUITING
NCT07546292Enhancing Letter-Speech Sound Learning and Reading Network Activation With Transcranial Electrical StimulationRECRUITING
NCT07534319Investigation of Brain Blood Flow Changes in Acute Ischemic Stroke Patients After Successful Endovascular ThrombectomyRECRUITING
NCT07531238Transcranial Temporal Interference Stimulation (tTIS) To Modulate Essential TremorNOT_YET_RECRUITING
NCT07256704Hypnosis and Attention in Patients With a Neurological Disease (Stroke, Traumatic Brain Injury and Multiple Sclerosis)RECRUITING
NCT07170150A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseaseRECRUITING
Research evidence trail
PUBMEDAntigen-specific activation of gut immune cells drives autoimmune neuroinflammation.2026-12-31
PUBMEDDissociation as a marker of emotion dysregulation: An examination in adolescent psychiatric inpatients using ecological momentary assessment.2026-12-15
PUBMEDAttenuating trauma- and cocaine-related intrusions by blocking memory reconsolidation with minocycline: protocol for a transdiagnostic randomized controlled trial.2026-12-01
PUBMEDThe relationship between age of first exposure and posttraumatic symptoms: results from the global psychotrauma screen.2026-12-01
PUBMEDAssessment of functional impairment related to post-traumatic stress in children and adolescents: a systematic review.2026-12-01
PUBMEDClinical and psychosocial factors related to change and therapy attendance during cognitive-behavioral therapy for young people at ultra high-risk of psychosis.2026-12-01
PUBMEDMarked elevation of alkaline phosphatase in an infant treated with levetiracetam: A case report.2026-12-01
PUBMEDThe German version of the Sleep Inertia Questionnaire in central disorders of hypersomnolence: a validation study.2026-12-01
PUBMEDFrom trigger to response: an ecological momentary study of intrusive memory sequences in PTSD and complex PTSD.2026-12-01
PUBMEDDaratumumab Treatment in Severe Anti-NMDAR Encephalitis: Two Case Reports and Literature Review.2026-11-01
PUBMEDChanging Patterns of Recent Substance Use in Emerging Adulthood and Their Associations With Cognitive Functions and Mental Health.2026-11-01
World Bank context
Macro indicators are shown only where a timestamped World Bank source row exists. They are context, not NeuroRisk predictions.
Sources and provenance
ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.
Limitations
Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.